Neil Martin

2.1k total citations · 1 hit paper
62 papers, 1.0k citations indexed

About

Neil Martin is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Neil Martin has authored 62 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Physiology, 34 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Neil Martin's work include Asthma and respiratory diseases (47 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (15 papers). Neil Martin is often cited by papers focused on Asthma and respiratory diseases (47 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (15 papers). Neil Martin collaborates with scholars based in United Kingdom, United States and France. Neil Martin's co-authors include Ian Pavord, Jean‐Pierre Llanos, David Halpin, David A. Lipson, J. Chiras, Robert A. Wise, Fernando J. Martínez, Andrew Menzies‐Gow, Mark T. Dransfield and Dave Singh and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Neil Martin

60 papers receiving 987 citations

Hit Papers

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: P... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
    2023 95 citations Jonathan Corren, Andrew Menzies‐Gow et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Martin United Kingdom 20 646 581 131 125 120 62 1.0k
Mandel Sher United States 11 222 0.3× 298 0.5× 75 0.6× 44 0.4× 107 0.9× 40 581
Dilini Vethanayagam Canada 13 310 0.5× 260 0.4× 106 0.8× 95 0.8× 135 1.1× 36 622
Alan B. Goldsobel United States 12 204 0.3× 140 0.2× 190 1.5× 60 0.5× 161 1.3× 47 730
Spyridon Papiris Greece 14 208 0.3× 414 0.7× 48 0.4× 94 0.8× 44 0.4× 41 607
Bruno Sposato Italy 14 306 0.5× 398 0.7× 59 0.5× 39 0.3× 62 0.5× 56 639
G.K. Knowles United Kingdom 5 698 1.1× 372 0.6× 235 1.8× 296 2.4× 134 1.1× 6 898
M. Shelley United Kingdom 8 1.4k 2.1× 982 1.7× 222 1.7× 476 3.8× 165 1.4× 17 1.7k
L Schwartz United States 7 520 0.8× 262 0.5× 205 1.6× 215 1.7× 230 1.9× 11 909
Kensuke Fukumitsu Japan 16 353 0.5× 368 0.6× 86 0.7× 34 0.3× 61 0.5× 73 634
Susana Marinho United Kingdom 15 368 0.6× 183 0.3× 435 3.3× 110 0.9× 81 0.7× 29 835

Countries citing papers authored by Neil Martin

Since Specialization
Citations

This map shows the geographic impact of Neil Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Martin more than expected).

Fields of papers citing papers by Neil Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Martin. The network helps show where Neil Martin may publish in the future.

Co-authorship network of co-authors of Neil Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Martin. A scholar is included among the top collaborators of Neil Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Martin. Neil Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourdin, Arnaud, Guy Brusselle, Simon Couillard, et al.. (2024). Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 809–823. 24 indexed citations
2.
Le, Tham, David Price, Bill Cook, et al.. (2024). Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry. Journal of Asthma and Allergy. Volume 17. 1055–1069. 5 indexed citations
3.
Wechsler, Michael E., Guy Brusselle, J. Christian Virchow, et al.. (2024). Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies. European Respiratory Journal. 64(6). 2400316–2400316. 19 indexed citations
4.
Brightling, Christopher E., Marco Caminati, Jean‐Pierre Llanos, et al.. (2024). Biomarkers and clinical outcomes after tezepelumab cessation. Annals of Allergy Asthma & Immunology. 133(3). 310–317.e4. 7 indexed citations
5.
Buhl, Roland, Jonathan Corren, Nicola A. Hanania, et al.. (2023). Tezepelumab in patients with allergic and eosinophilic asthma. Allergy. 79(5). 1134–1145. 19 indexed citations
6.
Laidlaw, Tanya M., Andrew Menzies‐Gow, Joseph K. Han, et al.. (2023). Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR. Journal of Asthma and Allergy. Volume 16. 915–932. 30 indexed citations
7.
Mathur, Sameer K., Jennifer Hill, Christopher S. Ambrose, et al.. (2023). Effect Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Age Of Onset, Allergic Status, And Eosinophilic Phenotype. Journal of Allergy and Clinical Immunology. 151(2). AB17–AB17. 1 indexed citations
8.
Corren, Jonathan, Andrew Menzies‐Gow, Geoffrey Chupp, et al.. (2023). Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 208(1). 13–24. 95 indexed citations breakdown →
9.
Bernstein, Jonathan A., Jean‐Pierre Llanos, Gillian Hunter, Neil Martin, & Christopher S. Ambrose. (2023). Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review. Advances in Therapy. 40(11). 4721–4740. 8 indexed citations
10.
Ambrose, Christopher S., Elliot Israel, Karin Bowen, et al.. (2023). Reply to Lipworth and Chan. American Journal of Respiratory and Critical Care Medicine. 208(2). 212–213. 1 indexed citations
11.
Corren, Jonathan, Michael E. Wechsler, Geoffrey Chupp, et al.. (2022). Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma. The Journal of Allergy and Clinical Immunology In Practice. 11(3). 943–945.e2. 1 indexed citations
12.
Halpin, David, Sally Worsley, Afisi Ismaila, et al.. (2021). INTREPID: single-versusmultiple-inhaler triple therapy for COPD in usual clinical practice. ERJ Open Research. 7(2). 950–2020. 46 indexed citations
13.
Han, MeiLan K., Gerard J. Criner, Mark T. Dransfield, et al.. (2021). Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis. ERJ Open Research. 7(1). 663–2020. 7 indexed citations
14.
Moore, Wendy C., Oliver Kornmann, Marc Humbert, et al.. (2021). Stoppingversuscontinuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study). European Respiratory Journal. 59(1). 2100396–2100396. 71 indexed citations
15.
Han, MeiLan K., Gerard J. Criner, Mark T. Dransfield, et al.. (2020). The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 202(9). 1237–1243. 20 indexed citations
16.
Lipson, David A., Courtney Crim, Gerard J. Criner, et al.. (2020). Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 201(12). 1508–1516. 146 indexed citations
17.
Ferguson, Gary T., Nicola J. Brown, Chris Compton, et al.. (2020). Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respiratory Research. 21(1). 131–131. 26 indexed citations
18.
Hawley, Daniel, Eileen Baildam, Tania Amin, et al.. (2012). Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Lara D. Veeken. 51(7). 1235–1239. 23 indexed citations
19.
Martin, Neil, Greer Arthur, Lucy Woodman, et al.. (2012). Primary Human Airway Epithelial Cell-Dependent Inhibition of Human Lung Mast Cell Degranulation. PLoS ONE. 7(8). e43545–e43545. 33 indexed citations
20.
Martin, Neil & Ian Pavord. (2008). Bronchial thermoplasty for the treatment of asthma. Current Allergy and Asthma Reports. 9(1). 88–95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mandel Sher Breakdown of academic impact, for papers by Dilini Vethanayagam Breakdown of academic impact, for papers by Alan B. Goldsobel Breakdown of academic impact, for papers by Spyridon Papiris Breakdown of academic impact, for papers by Bruno Sposato Breakdown of academic impact, for papers by G.K. Knowles Breakdown of academic impact, for papers by M. Shelley Breakdown of academic impact, for papers by L Schwartz Breakdown of academic impact, for papers by Kensuke Fukumitsu Breakdown of academic impact, for papers by Susana Marinho
Rankless by CCL
2026